Trait Biosciences Congratulates Dr. Richard Sayre and The New Mexico Consortium on Their Publication in Scientific Reports


Trait Acquires Exclusive License to Apply These New Technologies to Cannabis, Hemp

LOS ALAMOS, N.M. , Sept. 12, 2019 /CNW/ — Trait Biosciences Inc. (“Trait” or the “Business“), a biotechnology leader in the cannabis sector, right now congratulated its Chief Science Officer, Dr. Richard Sayre , and a group of sector scientists on the publication of the report “Fine-tuning the Photosynthetic Light Harvesting Apparatus for Enhanced Photosynthetic Efficiency and Biomass Yield” (the “Write-up“) in the September 2019 edition of Scientific Reports.

The operate that led to publication of the Write-up was performed by Dr. Sayre and the group at the New Mexico Consortium (“NMC“) on Camelina sativa (a plant that has a dense vertical canopy architecture related to cannabis and hemp) more than a three year period, via a grant from Bayer Crop Sciences.

The technologies created resulted in a 40% enhance of biomass production in field trials by fine-tuning the photosynthetic light harvesting apparatus in the plant to a lot more effectively make use of light.

“Photosynthesis has an all round power conversion efficiency of four%. By optimizing a plant’s light harvesting efficiency, we are approaching the theoretical efficiency limit of 12% resulting in substantial crop yield improvements and shorter increasing cycles,” mentioned Dr. Sayre. “These improvements will also lower the want for supplemental light in greenhouse cultivation systems. Importantly, this breakthrough is applicable to all crops and enables a substantial acquire in yield which is crucial for minimizing land use when preserving crop output.”

More than 14 patents and patent applications have resulted from these efforts, like PCT/US2015/041617 “Enhanced Carbon Fixation in Plants and Algae”, PCT/US2015/060448 “Transgenic Plants with Engineering Redox Sensitive Modulation of Photosynthetic Antenna Complicated Pigments and Procedures of Creating Very same” and PCT/US19/24669 “The Enhancement of Photosynthetic Prices, Abiotic Tension Tolerance and Biomass Yield Via Expression of a C4 Plant Ferredoxin in C3 Photosynthetic Plants”.

A copy of the Write-up is obtainable at 

Trait Acquires Exclusive License for Cannabis, Hemp and Tobacco Applications

Trait is also pleased to announce that it has entered into a patent license agreement (the “Exclusive License“) to obtain the exclusive rights to the Patents for use in cannabis, hemp and tobacco plants.

Below the terms of the Exclusive License, Trait will have the exclusive ideal to use the technologies contemplated by the Patents for use in cannabis, hemp and tobacco plants for the lifetime of the patent underlying the applicable technologies.

Peter McDonough , CEO of Trait, commented: “We present our most genuine congratulations to Dr. Sayre and his group on the publication of the report in Scientific Reports. It is a wonderful accomplishment.” McDonough added: “We are particularly pleased to be licensing these technologies, which vastly improve the photosynthetic yields of plants, and type one particular of the crucial tactics in our Trait Amplified technologies. Trait Amplified promises to enhance cannabinoid yields by a lot more than 4x, and reduce production expenses in cannabis and hemp plants. What is a lot more, these technologies reduce the environmental influence of cultivating hemp and cannabis by minimizing the inputs expected to develop these plants.”

About Trait Biosciences

With a group of internationally recognized scientists who are applying greatest-in-class technologies and agricultural science, Trait Biosciences is an emerging biotechnology leader in the hemp and cannabis industries. Its customer technologies platforms deliver breakthrough IP and science which create enhanced cannabinoids featuring predictable onset timing, superior bioavailability, extended stability, and enhanced taste.  Trait’s patent pending technologies incorporate a method for producing water-soluble cannabinoids that does not rely on emulsion or nanotechnology.  The company’s agricultural technologies enhance crop yields and plant security, like ultrahigh yield Amplified&#x2122 plants which substantially enhance a plant’s all-natural cannabinoid productivity, and its Defence&#x2122 RNAi crop protection technologies, which eliminates the want for pesticides or fungicides, giving greater high quality, safer, CBD-infused nutraceutical and pharmaceutical goods.

Cautionary Statement on Forward-Hunting Information 

Specific facts contained in this press release, like any facts as to Trait Bioscience Inc.’s (the “Corporation”) method, projects, plans or future monetary or operating functionality, constitutes “forward-seeking statements”. All statements, other than statements of historical truth, are forward-seeking statements. The words “promises,” “will”, “anticipate”, “continue”, “assess”, “anticipate” and related expressions recognize forward-seeking statements. Forward-seeking statements are necessarily primarily based upon a quantity of estimates and assumptions like material estimates and assumptions that, when regarded affordable by the Corporation as at the date of this press release in light of every single of management’s practical experience and perception of present situations and anticipated developments, are inherently topic to considerable company, financial and competitive uncertainties and contingencies. Identified and unknown components could bring about actual final results to differ materially from these projected in the forward-seeking statements and undue reliance should really not be placed on such statements and facts. 

Any forward-seeking statements incorporated in this document are created as of the date of this document and the Corporation disclaims any intention or obligation to update or revise any forward-seeking statements, irrespective of whether as a outcome of new facts, future events or otherwise. Though management of the Corporation believes that the expectations represented in such forward-seeking statements are affordable, there can be no assurance that such expectations will prove to be right.

MEDIA Speak to:

Thomas Walek
Peaks Strategies 
[email protected]

View original content material:

Supply Trait Biosciences Inc.

View original content material:


Latest posts